SAN DIEGO, June 15, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that the GoodRx class action lawsuit seeks to represent purchasers or acquirers of GoodRx Holdings, Inc. (NASDAQ:GDRX) common stock between September 23, 2020 and November 8, 2022, all dates inclusive (the "Class Period"), have until June 21, 2024 to seek appointment as lead plaintiff of the GoodRx class action lawsuit. Captioned Barsuli v. GoodRx Holdings, Inc., No. 24-cv-03282 (C.D. Cal.), the GoodRx class action lawsuit charges GoodRx as well as certain of GoodRx's top executives and directors with violations of the Securities Exchange Act of 1934.
If you suffered substantial losses and wish to serve as lead plaintiff of the GoodRx class action lawsuit, please provide your information here:
https://www.rgrdlaw.com/cases-goodrx-holdings-inc-class-action-lawsuit-gdrx.html
You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at info@rgrdlaw.com. Lead plaintiff motions for the GoodRx class action lawsuit must be filed with the court no later than June 21, 2024.
CASE ALLEGATIONS: GoodRx operates a price comparison platform for prescription drugs which, in many cases, offers consumers access to lower prices (through discount codes and coupons) for their medications. GoodRx also generates a portion of its revenue from subscription plans like the "Kroger Rx Savings Club," which provides "access [to] lower prescription prices at" pharmacies operated by The Kroger Co.
The GoodRx class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) while ...